No profile data available.
Novo Integrated Sciences, Inc. (NVOS) is a healthcare company in the general medical services industry, based in Bellevue, United States, with about 115 full-time employees.
It reported revenue of $12.57 million for fiscal year 2023, up 7.1% from fiscal year 2022, and net income of -$13.21 million. In Q3 2024 (the quarter ended May 31, 2024) revenue was $3.15 million, down 4.3% from a year before. Its largest business segment, Healthcare Services, brought in 62% of segment revenue in fiscal year 2024. Its market capitalization was $27,622 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended August 31, 2023; market data as of October 8, 2026.
, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales.
Novo Integrated Sciences reported $12.57 million in revenue for fiscal year 2023, up 7.1% from $11.74 million in fiscal year 2022. In Q3 2024 revenue was $3.15 million.
Healthcare Services, with $8.30 million or 62% of segment revenue in fiscal year 2024. Next: Product Sales (37%) and Corporate (1%).
$27,622 as of October 8, 2026.
Listed companies of a similar size in the same industry (general medical services) include DocGo Inc. (DCGO), First Choice Healthcare Solutions, Inc. (FCHS).